Spasmex

Spasmex contains trospium chloride, an anticholinergic agent that acts as a muscarinic receptor antagonist. It reduces the contractile tone of smooth muscle in the bladder, thereby increasing bladder capacity and delaying the initial desire to void.

Dosage by Body Weight

The standard adult dose is 20 mg twice daily, or 15 mg to 30 mg two to three times daily, taken on an empty stomach at least one hour before meals. Dosage should be reduced in patients with severe renal impairment.

  1. Body Weight
    Below 5 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.
  2. Body Weight
    5-7 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.
  3. Body Weight
    8-10 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.
  4. Body Weight
    11-15 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.
  5. Body Weight
    16-20 kg
    Dose
    Not recommended
    Frequency
    Do not use
    Tracking Notes
    Safety and effectiveness in pediatric patients have not been established.

Formulation

Tablet

Purpose

Treatment of overactive bladder (OAB) symptoms including urinary frequency, urgency, and urge incontinence.

Generic Name

Trospium chloride

Scheduled Drug

Yes. This medicine should be supplied or used only according to applicable prescription and regulatory requirements.

Alternatives

SancturaVesicareDitropanDetrolToviaz

Disclaimer: This information is for educational purposes only. WHO references and weight bands are simplified for tracking and must not replace medical advice. Always consult with a healthcare professional before starting or changing any medication.